Clínic-IDIBAPS, a key role in developing the Hipra vaccine
The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various servic1
The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various servic1
One in three patients in the study had a “viral storm”, showing signs of an increased inflammatory response.
There has been an outbreak of a virus similar to Ebola, the Marburg virus, in Equatorial Guinea. There are no cases outside Africa, but governments a1
Clínic Barcelona-IDIBAPS researchers have demonstrated that replacing the immunosuppressant drug tacrolimus with prednisone prevents the appearance o1
It originated in October last year in the US and could become the dominant variant.
This winter, the epidemiological situation will be difficult: there are cases of bronchiolitis, COVID, flu and the usual coughs and colds. A veritabl1
As part of Science Week 2022, IDIBAPS organised a new edition of the activity for secondary and baccalaureate students, which took place on Wednesday1
Eighty per cent of the population of our country has consumed alcohol in the last year. It is estimated that around 10% are daily drinkers and over1
The COVID-19 pandemic generated a unique scenario to analyse the psychological impact of global and extreme situations on the population. Now, a stud1
The mortality rate during the first month of infection for patients with advanced-stage hepatocellular carcinoma rose to 20.7%.